Nilvanstomig
Nilvanstomig (ZG005) is an antibody targeting PD-1 and TIGIT. Nilvanstomig blocks the PD-1/TIGIT pathway, thereby promoting the synergistic activation of T cells and enhancing the anti-tumor activity of NK cells. Nilvanstomig is applicable to relevant research on advanced cervical cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3061475-22-4
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
immunoglobulin (H-gamma4-scFvhk_L-kappa) dimer
Human
PDCD1/PD-1/CD279 & TIGIT
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG4-kappa-[scFv]2
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 3061475-22-4
-
SMILES
[Nilvanstomig]
-
Synonyms
ZG005
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)